SCHEMBL7877994

SCHEMBL7877994

CNc1c(C=O)cccc1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ MMP14 P50281 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ POLB P06746 4/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ ALOX15 P16050 1/20 0.40
▸ HPGD P15428 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ CLCN2 P51788 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ERN1 O75460 2/20 0.38
▸ AKR1C3 P42330 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3644862 0.82 ALDH1A1 (0.52) KDM4ESMN1; SMN2MAPTMAPK1MMP14
SCHEMBL6874838 0.78 ATR (0.36) KDM4EALDH1A1POLBERN1MEN1
SCHEMBL165558 0.76 POLB (0.61) KDM4ESMN1; SMN2MAPTMAPK1MMP14
SCHEMBL29954239 0.76 ERN1 (0.55) MAPTALDH1A1POLBTDP1LMNA
SCHEMBL1681296 0.76 CA12 (0.54) KDM4ESMN1; SMN2MAPTMAPK1MMP14
SCHEMBL1058986 0.76 ALDH1A1 (0.56) KDM4ESMN1; SMN2ALDH1A1POLBL3MBTL1
SCHEMBL7575587 0.76 CLCN2 (0.49) KDM4ESMN1; SMN2MAPTMAPK1MMP14
SCHEMBL7308406 0.76 TSHR (0.59) KDM4ESMN1; SMN2MAPTMAPK1MMP14
Ethane SCHEMBL28912389 0.75 ALDH1A1 (0.54) KDM4ESMN1; SMN2MAPTALDH1A1POLB
Methyl Alcohol SCHEMBL27944949 0.75 ALDH1A1 (0.54) KDM4ESMN1; SMN2MAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10400138-B2 Extended performance bird repellent exterior coating ARKION LIFE SCIENCES, LLC (US) 2019-09-03 — — US disclosed
US-9999220-B2 Method for repelling rodents THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2018-06-19 — — US disclosed
US-20170367327-A1 EXTENDED PERFORMANCE BIRD REPELLENT EXTERIOR COATING ARKION LIFE SCIENCES (US) 2017-12-28 — — US disclosed
US-20150196026-A1 METHOD FOR REPELLING RODENTS ARKION LIFE SCIENCES, LLC (US) 2015-07-16 — — US disclosed
WO-2015106266-A1 METHOD FOR REPELLING RODENTS ARKION LIFE SCIENCES, LLC (US) 2015-07-16 — — WO disclosed
US-6328986-B1 Method of deterring birds from plant and structural surfaces ARKION LIFE SCIENCES 2001-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150196026-A1 METHOD FOR REPELLING RODENTS KEAP1, NQO1, DLAT KDM4E 2715/4885SMN1; SMN2 4155/4885MAPT 4250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback